Πρωτεύουσες καρτέλες
Ο κατάλογος των δημοσιεύσεων είναι ενδεικτικός και μπορεί να μην περιλαμβάνει το σύνολο των δημοσιεύσεων.
Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece..
Hemoglobin. 46(2), 143-145.
(2022).
Cutaneous manifestations of mantle cell lymphoma: an extensive literature review..
Acta Dermatovenerol Alp Pannonica Adriat. 29(4), 185-191.
(2020).
Biochemical and imaging markers in patients with thalassaemia..
Hellenic J Cardiol.
(2020).
Necrobiosis Lipoidica in a Patient with β-Thalassemia Major: A Case Report and Review of the Literature..
Hemoglobin. 44(3), 221-223.
(2020).
Coinheritance of Triplicated Alpha-Globin Gene and Beta-Thalassemia Mutations in Adulthood: Ten Years of Referrals in Northern Greece..
J Pediatr Hematol Oncol. 42(8), e762-e764.
(2020).
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia..
N Engl J Med. 382(13), 1219-1231.
(2020).
Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients..
Pharmacogenomics. 20(11), 791-801.
(2019).
Beta-thalassemia: renal complications and mechanisms: a narrative review..
Hematology. 24(1), 426-438.
(2019).
National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality..
Ann Hematol. 98(1), 55-66.
(2019).
Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis..
Metabolism. 87, 18-24.
(2018).
Deferasirox improves liver fibrosis in beta-thalassaemia major patients. A five-year longitudinal study from a single thalassaemia centre..
Br J Haematol. 181(1), 140-142.
(2018).
Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia..
Hemasphere. 2(5), e58.
(2018).
A man with fever and haemoglobinuria after blood transfusion..
BMJ. 362, k3138.
(2018).
Successful Outcome of Severe Intra-cerebral Bleeding Associated with Acquired Factor V Inhibition: Utilization of Multiple Therapeutic Agents..
Balkan Med J. 35(1), 112-115.
(2018).
Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea..
Hum Genomics. 12(1), 45.
(2018).
Safety and efficacy of intravenous iron administration for uterine bleeding or postpartum anaemia: a narrative review..
J Obstet Gynaecol. 38(4), 443-447.
(2018).
Production and Transduction of a Human Recombinant β-Globin Chain into Proerythroid K-562 Cells To Replace Missing Endogenous β-Globin..
Mol Pharm. 15(12), 5665-5677.
(2018).
Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition..
Hemoglobin. 42(5-6), 339-341.
(2018).
β-Thalassemia and renal complications. A narrative review of pathophysiologic mechanisms.
Integrative Molecular Medicine. 5(4),
(2018).
Association between response rates and survival outcomes in patients with newly diagnosed multiple myeloma. A systematic review and meta-regression analysis..
Eur J Haematol. 98(6), 563-568.
(2017).
Presence of the IVS-I-6-Mutated Allele in Beta-Thalassemia Major Patients Correlates with Extramedullary Hematopoiesis Incidence..
Acta Haematol. 137(3), 175-182.
(2017).
Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease..
Br J Haematol. 178(1), 130-136.
(2017).